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Acute Appendicitis-Pledger and Buchan
Conclusions
While there are still many difficulties in the diagnosis of acute appendicitis a considerable proportion of the children dying in hospital were suffering from potentially remediable effects of the disease. It seems that a more widespread application of accepted lines of treatment might reduce the mortality rate further.
Though we were looking only at deaths from acute appendicitis it is likely that the conclusions we have drawn about fluid balance, anaesthesia, and the treatment of hyperpyrexia and convulsions will be applicable to children suffering from other diseases and from trauma. This type of national medical audit should be used more extensively, on the lines of the Confidential Enquiry into Maternal Deaths.
There is a need in the health service to expend effort and money on absorbing knowledge and techniques into universal practice, and to ensure that patients are admitted to hospitals which can provide the facilities and skills appropriate to their requirements.
We wish to thank the many people who wrote to us or lent us case notes, and Mr. P. F. Jones for his helpful comments. We are also grateful to the Registrar General's staff for their valuable assistance.
Introduction
Trimethoprim (2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine) is a dihydrofolate reductase inhibitor (Roth, Falco, Hitchings, and Bushby, 1962) . Since it selectively inhibits the bacterial rather than the mammalian enzyme it can be used as an antibacterial agent in man. Its activity is much enhanced If it is combined with a sulphonamide, and, indeed, in vitro the two can be shown to have a synergistic effect (Elionl, Singer, and Hitchings, 1954.; Bushby and Hitchings, 1968) . Darrell, Garrod, and Waterworth (1968) showed that while the action of either drug is bacteriostatic, when they are used in combination this becomes bactericidal. Besides its activity against Gram-negative bacilli such as Escherichia coli and Proteus sp., the combination is also effective in vitro against such pathogens as Haemophilus influenzae and Streptococcus pneumoniae (Bushby and Barnett, 1967) . It has therefore been used in the treatment of exacerbations of chronic bronchitis. Clinical trials with the combination have been reported in urinary infections (Reeves, Faiers, Pursell, and Brumfitt, 1969;  Grfineberg and Kolbe, 1969), but only brief reports of its * Senior Lecturer in Medicine, the London Hospital, London E.1.
Methods
Fifty cases fulfilling the Medical Research Council criteria for chronic bronchitis (M.R.C., 1965) were selected. All of them had had symptoms for more than five years. There were 44 men and 6 women. They all had acute exacerbations of bronchitis leading to an increase in dyspnoea, cough, sputum volume, and purulence. The majority of them needed hospital admission, though 10 (five from each of two treatment groups) were treated as outpatients.
Comparison was made between the effect of a week's course of ampicillin 500 mg. four times a day and trimethoprim (TMP)-sulphamethoxazole (SMZ). This was administered as two Septrin tablets twice a day, each containing 80 mg. of TMP and 400 mg. of SMZ, so that the total daily dosage was 320 mg. of TMP and 1,600 mg. of SMZ. TMP/SMZ combinations are administered only twice daily because of their relatively long half-life in the body of 13 to 15 hours. Because of the difference in presentation (capsules as compared with tablets) and in the number of times of administration a completely double-blind trial was not feasible. It was therefore carried out as a single-blind trial. Sufficient tablets or capsules to make 'up a week's course of either treatment were put up in 50 numbered boxes with a slip inside instructing the patient how to take them. There were 25 one-week courses of each treatment, which were randomly allocated to the patients without the medical attendants knowing which the patient was receiving, and the code was not broken until the trial was completed or, in two instances, when the treatment had failed (see below).
The two treatment groups were comparable in that the mean length of the history of the 25 patients receiving ampicillin was 13-5 years and that of the group receiving the TMP/SMZ combination was 156 years. The rate of admission to hospital with exacerbations of bronchitis in the preceding three years was also comparable, the mean for the group receiving ampicillin being 1-04 and for the combination 1-2. They had all received various antibiotics during preceding winters. In this particular trial, however, ampicillin or TMP/SMZ was the primary treatment, with one exception. This was a 61-year-old man with severe puruleint bronchitis who had spent most of the preceding winter in hospital. He was included in the trial as he had failed to respond to treatment with tetracycline and chloramphenicol, so that the Pseudomonas pyocyanea cultured from his sputum may not have been the primary pathogen.
Sputum Examination.-Specimens of sputum were examined fresh each day in order to assess the degree of purulence. They were graded on the M.R.C. (1965) scale, ranging from Ml (the most niucoid) to P3 (the most purulent). All sputum expectorated in the first two hours of each day was carefully collected in graduated cartons and its volume measured. The sputum was cultured on Oxoid diagnostic sensitivity medium with added 5% lysed horse blood, and the sensitivity of any organisms grown tested against standard discs of penicillin, ampicillin, streptomycin, tetracycline, and the combination (in this case containing 23-75 ,ug. of sulphamethoxazole and 1-25 p,g. of trimethoprim per disc). In a few cases sensitivities to other antibiotics were also investigated. Cultures were taken before and after treatment.
Blood Counts.-All patients had haemoglobin estimations, white cell and differential counts, and platelet counts carried out before and after treatment.
Other Tests.-All patients had x-ray examinations, while many also had other investigations, such as electrocardiograms and pulmonary function tests.
Clinical Assessment.-A simple clinical assessment of the response to treatment was also made, taking into account changes in the patient's symptoms and signs.
Results
Sputum Volumes.-These were reduced by either treatment. The TMP/SMZ combination produced a significantly greater reduction in volume (Table I) . 
(1) and (2) differ significantly (0-05 > P > 0-01).
Sputum Purulence.-This was more difficult to assess, particularly as in practice the difference between M.R.C. grades are not always easy to judge. A change from predominantly purulent (M.R.C. grades P1-3) to predominantly or wholly Table III . The combination eradicated pathogens in 15 out of 16 patients, while ampicillin did so in only 9 out of 13 cases. Though these results favour the combination they are not statistically significant (see Table IV ). Table II .
Side-effects.-There was no significant effect on the blood counts produced by either treatment, nor was there a significant difference in the effect produced by each (Table V) (Burns and May, 1967) . In the present study these were again the commonest organisms found. A number of Gram-negative bacilli were also isolated from the sputum, however. This may reflect a change in the bacterial flora causing chest infections, especially in hospital, and it is such Gram-negative bacilli that may be more difficult to treat (Watt and Okubadejo, 1967; Lancet, 1969 Hughes et al. (1969) . Pines (1969) (Bushby and Hitchings, 1968) . In a recent clinical study Pechere and Beck (1969) found that after oral administration of the combination the level of trimethoprim in the sputum was always greater than that in the blood by a factor of about 2 5. The level of sulphamethoxazole in sputum, however, was always lower than that in serum by a factor of about 0 3. This means that in sputum the ratio of the drugs may be quite different from that in which it was administered by mouth-namely, TMP: SMZ=2 5: 17. It therefore appears that trimethoprim may reach a higher concentration in the lung and bronchial secretion than sulphamethoxazole. Be that as it may, this combination, with its sequential blockade of folate metabolism, is undoubtedly an effective one and relatively small doses of the two constituents need be used.
The combination may also be useful in the long-term chemoprophylaxis of chronic bronchitis. In spite of a number of trials, including some quite extensive ones carried out by the Medical Research Council and the British Tuberculosis Association-for example, Pridie et al. (1960) , Francis, May, and Spicer, 1964; M.R.C., 1966) Journal, 1969, 4, 473-474 Hb H disease is one of the a-thalassaemia syndromes. The a-thalassaemias are a heterogeneous group of conditions due to an inherited defect of the synthesis of the a-chains of Hb A (aj2)2) (Huehns, 1965 ; Weatherall, 1965 ). According to current concepts there are believed to be two a-thalassaemic genes involved in these syndromes, a' and a2 (Weatherall, 1969 Suingdumrong, 1964) . The amount of Hb Bares present is indicative of the degree of a-chain suppression and the type of a.-thalassaemia inherited-25% =-al/a2 (Hb H disease), 5-10%S =aO/a (a-halasaemia trait), and 1-2% =a2/a (a2-thalassaemia trait).
We report the management of a pregnancy in a woman suffering from Hb H disease.
CASE REPORT FAMILY STUDY
The patient was a 34-year-old Greek Cypriot. In 1958 she was investigated at Hammersmith Hospital for a chronic haemolytic anaemia, which proved to be Hb H disease. She returned to Hammersmith Hospital in 1968 for management of her pregnancy, and the following haematological investigations were carried out to confirm the diagnosis. Incubation of the red cells with new methylene blue showed that 85% of them contained inclusions of typical Hb H. and on starch-gel electrophoresis at pH 8-6 2-5% of the haemoglobin was fast-running. The globin of the fastrunning haemoglobin was prepared by acid acetone precipitation after separation and elution of the haemoglobin by starch-block electrophoresis. The peptide chains of the globin were examined by CMC chromatography in 8M urea/mercaptoethanol buffers (Clegg, Naughton, and Weatherall, 1966) , and it was found to consist entirely of fiA-chains. Thus the Hb H disease was confirmed.
Her husband and her father were investigated at the same time to determine whether they were affected by one of the a-thalassaemia syndromes. Neither her father nor her husband was anaenmic, but both had slightly hypochromic blood films, a decrease in the osmotic fragility of their red cells, an occasional Hb-H-containing red cell, and trace amounts of Hb H, detectable by starch-gel electrophoresis at pH 7. These findings suggest that both her father and her husband had a'-thala'ssaemia trait (a/a), The patient's mother was not available for study, but she was believed to be normal haematologically. Nevertheless, because the patient had inherited both a'-and a'-thalassaemia genes, the mother must carry the a'-thalassaemia gene.
